NAT2 and tuberculosis: To validate our findings, we established a replication cohort comprising patients with both active TB (n = 101) and latent TB (n = 64) who were treated with the standard TB regimen and INH monotherapy, respectively, and conducted NAT2 and ATP7B genotyping.